MORFEO enters final design phase

MORFEO (Multi-conjugate adaptive Optics Relay For ELT Observations, formerly MAORY), the MCAO system for the ELT, will provide diffraction-limited optical quality to the large field camera MICADO. MORFEO has officially passed the Preliminary Design Review and it is entering the final design phase. We present the current status of the project, with a focus on the adaptive optics system aspects and expected milestones during the next project phase

Soft and Hard Iron Compensation for the Compasses of an Operational Towed Hydrophone Array without Sensor Motion by a Helmholtz Coil

Usually, towed hydrophone arrays are instrumented with a set of compasses. Data from these sensors are utilized while beamforming the acoustic signal for target bearing estimation. However, elements of the hydrophone array mounted in the neighborhood of a compass can affect the Earth’s magnetic field detection. The effects depend upon the materials and magnetic environment present in the vicinity of the platform hosting the compass. If the disturbances are constant in time, they can be compensated for by means of a magnetic calibration procedure. This process is commonly known as soft and hard iron compensation. In this paper, a solution is presented for carrying out the magnetic calibration of a COTS (Commercial Off the Shelf) digital compass without sensor motion. This approach is particularly suited in applications where a physical rotation of the platform that hosts the sensor is unfeasible. In our case, the platform consists in an assembled and operational towed hydrophone array. A standard calibration process relies on physical rotation of the platform and thus on the use of the geomagnetic field as a reference during the compensation. As a variation on this approach, we generate an artificial reference magnetic field to simulate the impractical physical rotation. We obtain this by using a tri-axial Helmholtz coil, which enables programmability of the reference magnetic field and assures the required field uniformity. In our work, the simulated geomagnetic field is characterized in terms of its uncertainty. The analysis indicates that our method and experimental set-up represent a suitably accurate approach for the soft and hard iron compensation of the compasses equipped in the hydrophone array under test

The PlasticPelagos Project: microplastics, convergence areas and fin whales in the Pelagos Sanctuary (northwestern Mediterranean Sea)

The Mediterranean Sea is one of the areas most affected by litter in the world. The highest percentage (~80%) of marine litter consists of plastic including microplastics (plastic fragments smaller than 5 mm). Research on the impact of microplastics on large filter-feeding species, such as fin whale (Balaenoptera physalus), is still in its infancy. Here we present the results of the PlasticPelagos pilot project focused to investigate the overlap between microplastics and fin whale feeding ground in convergence areas (gyres) of the SPAMI Pelagos Sanctuary (northwestern Mediterranean Sea). A sampling cruise carried out in September 2014 along 967 miles allowed collecting surface microplastics samples (n=21), counting macrolitter, monitoring cetaceans and collecting skin biopsies of fin whales. Two operational models of ocean circulation (LaMMA) and fin whale potential habitat (JRC) were used to localize possible convergence areas of marine litter and probable presence of foraging fin whales respectively. A multi-layer approach was used to investigate the possible overlap between microplastics convergence areas and fin whale feeding ground. The three layers of field data, microplastics abundance (items-micro/m2), macroplastics abundance (items-macro/km2) and cetacean presence were compared with the maps of ocean circulation and fin whale potential feeding habitat. The plastic data set has revealed high occurrence of microplastics (from 0.009 to 0.260 items/m2) in the investigated surface neustonic/planktonic samples and a significant overlap with the areas showing high macroplastic density (0.6127, R. Spearman). Moreover the areas of high densities of microplastics detected on circulation maps largely overlapped with fin whale potential feeding grounds suggesting that whales are particularly exposed to microplastics threat when foraging in the Pelagos Sanctuary during summer. The ecotoxicological analysis of the collected fin whale skin biopsies will be carried out to elaborate further on this hypothesis

Plastic debris occurrence, convergence areas and fin whales feeding ground in the Mediterranean Marine Protected Area Pelagos Sanctuary: a modelling approach

The Mediterranean Sea is greatly affected by marine litter. In this area, research on the impact of plastic debris (including microplastics) on biota, particularly large filter-feeding species such as the fin whale (Balaenoptera physalus), is still in its infancy. We investigated the possible overlap between microplastic, mesoplastic and macrolitter accumulation areas and the fin whale feeding grounds in in a pelagic Specially Protected Area of Mediterranean Importance (SPAMI): the Pelagos Sanctuary. Models of ocean circulation and fin whale potential habitat were merged to compare marine litter accumulation with the presence of whales. Additionally, field data on microplastics, mesoplastics, and macrolitter abundance and cetacean presence were simultaneously collected. The resulting data were compared, as a multi-layer, with the simulated distribution of plastic concentration and the whale habitat model. These data showed a high occurrence of microplastics (mean: 0.082 items/m2, STD ± 0.079 items/m2) spatial distribution agreed with our modeling results. Areas with high microplastic density significantly overlapped with areas of high macroplastic density. The most abundant polymer detected in all the sampling sites was polyethylene (PE), suggesting fragmentation of larger packaging items as the primary source. To our knowledge, this is the first study in the Pelagos Sanctuary in which the simulated microplastic distribution has been confirmed by field observations. The overlap between the fin whale feeding habitat and the microplastic hot spots is an important contribution for risk assessment of fin whale exposure to microplastics.JRC.D.2-Water and Marine Resource

No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study

In this retrospective, multicenter, real-world study we collected clinical and magnetic resonance imaging (MRI) data of all patients (n = 40) with relapsing-remitting multiple sclerosis (RRMS) treated with alemtuzumab according to a "free-of-charge" protocol available before the drug marketing approval in Italy. Almost all (39/40) started alemtuzumab after discontinuing multiple disease-modifying treatments (DMTs) because of either lack of response or safety concerns. We considered the proportion of alemtuzumab-treated patients who had no evidence of disease activity (NEDA-3) and disability improvement over a 36-month follow-up period. NEDA-3 was defined as absence of relapses, disability worsening, and MRI activity. Disability improvement was defined as a sustained reduction of ≥ 1-point in Expanded Disability Status Scale (EDSS) score. At follow-up, 18 (45%) patients achieved NEDA-3, 30 (75%) were relapse-free, 33 (82.5%) were EDSS worsening-free, and 25 (62.5%) were MRI activity-free. Eleven (27.5%) patients had a sustained disability improvement. We found no predictor for the NEDA-3 status, while the interaction of higher EDSS score by higher number of pre-alemtuzumab relapses was associated with a greater chance of disability improvement (odds ratio 1.10, p = 0.049). Our study provides real-world evidence that alemtuzumab can promote clinical and MRI disease remission, as well as disability improvement, in a significant proportion of patients with RRMS despite prior multiple DMT failures. The drug safety profile was consistent with data available from clinical trials

Latent tuberculosis infection in patients with chronic plaque psoriasis: Evidence from the Italian Psocare Registry

Background The nationwide prevalence of latent tuberculosis infection (LTBI) in Italian patients with psoriasis has never been investigated.Objectives To estimate the nationwide prevalence of LTBI in Italian patients with psoriasis who are candidates for systemic treatment.Methods Data were obtained from the Psocare Registry on those patients (n = 4946) with age > 18 years, systemic treatment at entry specified and tuberculin skin test (TST) performed according to the Mantoux method. LTBI diagnosis was based on a positive TST result in the absence of any clinical, radiological or microbiological evidence of active tuberculosis.Results Latent tuberculosis infection was diagnosed in 8.3% of patients with psoriasis (409 of 4946). The prevalence of LTBI was lower in patients on biologics than in those on conventional systemic treatments, ranging from 4.3% (19 of 444) of patients on adalimumab to 31% (eight of 26) of those on psoralenultraviolet A (P < 0.05). Independent factors associated with LTBI were male sex [odds ratio (OR) 1.30, 95% confidence interval (CI) 1.04-1.62; P = 0.02], age over 55 years (OR 2.93, 95% CI 2.18-3.93; P < 0.001) and being entered into a conventional treatment (OR 3.83, 95% CI 3.10-4.74; P < 0.001). Positive history of tuberculosis was seen in 1% of patients (n = 49).Conclusions The nationwide prevalence of LTBI in Italian patients with psoriasis candidate to systemic treatment is high, and screening is recommended prior to biological treatment

Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry.

NCBINCBI Logo Skip to main content Skip to navigation Resources How To About NCBI Accesskeys Sign in to NCBI PubMed US National Library of Medicine National Institutes of Health Search database Search term Clear input Advanced Help Result Filters Display Settings: Abstract Send to: J Eur Acad Dermatol Venereol. 2013 Jan;27(1):e30-41. doi: 10.1111/j.1468-3083.2012.04450.x. Epub 2012 Feb 7. Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry. Gisondi P1, Cazzaniga S, Chimenti S, Giannetti A, Maccarone M, Picardo M, Girolomoni G, Naldi L; Psocare Study Group. Collaborators (368) Author information Abstract OBJECTIVE: To evaluate variations in laboratory parameters and diagnoses of selected clinical conditions up to 16 weeks after starting a new systemic psoriasis treatment for Psocare Registry enrollees. DESIGN: Prospective cohort study. SETTING: Italian public referral centres for psoriasis treatment. PATIENTS: First-time recipients (n = 10,539) of continuous systemic psoriasis treatment for at least 16 weeks. MAIN OUTCOME MEASURE: Mean variations in (weeks 8 and 16) and proportions of patients reaching a clinically meaningful increase in serum levels (week 16) of total and low-density lipoprotein cholesterol, triglycerides, aspartate amino transferase, alanine amino transferase and creatinine, as well as week-16 cumulative incidences of new diagnoses of diabetes mellitus and arterial hypertension. RESULTS: Mean cholesterol and triglyceride levels significantly increased in patients treated with acitretin or cyclosporine. Mean triglyceride levels also increased in efalizumab- and etanercept-treated patients. Mean transaminase values increased in methotrexate-treated patients, and mean aspartate amino transferase levels increased in infliximab-treated patients. The average serum creatinine value increased in cyclosporine-treated patients. Acitretin and cyclosporine were associated with risk of hypercholesterolaemia (odds ratios 1.51 and 1.34) and acitretin with risk of hypertriglyceridaemia (odds ratio 1.43). Methotrexate and infliximab were associated with risk of more than doubling the upper normal aspartate amino transferase (odds ratios 2.06 and 1.87) and alanine amino transferase (odds ratios 2.38 and 1.74) values. The relative risk of developing arterial hypertension and diabetes was increased for patients receiving cyclosporine (odds ratios 3.31 and 2.88). CONCLUSION: Systemic treatments for psoriasis resulted in heterogeneous effects on the parameters analysed